
Originally Posted by
Yurcha
Development of Azilect, a drug for Parkinson's disease, by Moussa Youdim and John Finberg from the Technion - Israel Institute of Technology, and commercialized by Teva Pharmaceutical Industries.
Development of the Copaxone immunomodulator drug for treating multiple sclerosis. It was developed in the Weizmann Institute of Science in Israel by Michael Sela, Ruth Arnon and Deborah Teitelbaum.
Development of the Interferon proteins by Michel Revel from the Weizmann Institute of Science in Israel.
Development of taliglucerase alfa (Elelyso), a recombinant glucocerebrosidase enzyme produced from transgenic carrot cell cultures.[19] Taliglucerase alfa won approval from the U.S. Food and Drug Administration in May 2012 as an orphan drug for the treatment of Type 1 Gaucher's disease.[20]